Helicobacter Infections: all 188 studies

Page 2 of 2. Open to participants first (33), then studies with results posted, then the rest; newest registration first within each.

• Dual-focus Magnification With Narrow-band Imaging in Helicobacter Pylori InfectionStatus unknownNCT03973242Not applicable
• One Sequencing Find All for Helicobacter Pylori InfectionStatus unknownNCT03837990
• Intraluminal Mono-antibiotic Therapy for Helicobacter Pylori Infection - A Comparison of Levofloxacin Powder and Levofloxacin SolutionCompletedNCT03832465Phase 4
• Association Between Helicobacter Pylori and Inflammatory Bowel DiseaseCompletedNCT03820284
• Analysis of the Impact of Helicobacter Pylori on Salivary Microbiome in AdultsStatus unknownNCT03730766Phase 4
• Efficacy and Safety of 14-day Concomitant Therapy for Helicobacter Pylori InfectionStatus unknownNCT03726099Phase 4
• Helicobacter Pylori Eradication Rates of Bismuth-containing Quadruple Therapy vs Modified Quadruple Therapy in KoreaCompletedNCT03665428Phase 4
• Efficacies of Antimicrobial Susceptibility-Guided Versus Empirical Therapy for Rescue Treatment of Helicobacter Pylori InfectionCompletedNCT03658746Phase 4
• A Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori InfectionStatus unknownNCT03658733Phase 4
• Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori InfectionStatus unknownNCT03616405Phase 4
• The Impact of Antibiotics MIC Value on the Efficacy of Treatment Regimens for Helicobacter Pylori Infection.Status unknownNCT03583476
• Comparison of Therapy in Treatment of Patients With Helicobacter Pylori Infection: Concomitant Versus Hybrid Therapy.CompletedNCT03572777Not applicable
• Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the First-line Helicobacter Pylori Eradication.Status unknownNCT03571230Phase 4
• Rapid Urease Test for Diagnosis Helicobacter Pylori InfectionCompletedNCT03547544
• Intraluminal Metronidazole Powder Monotherapy for Helicobacter Pylori InfectionCompletedNCT03524833Phase 4
• Intraluminal Amoxicillin Powder Monotherapy for Helicobacter Pylori InfectionCompletedNCT03521726Phase 4
• Intraluminal Clarithromycin Powder Monotherapy for Helicobacter Pylori InfectionCompletedNCT03516669Phase 4
• A Unique Regimen for Treatment of Helicobacter Pylori InfectionStatus unknownNCT03491995Phase 3
• Helicobacter Pylori Infection in Renal Transplant PatientsStatus unknownNCT03310255
• Sequential Versus Quadruple Therapy in the Second-line TreatmentStatus unknownNCT03208426Phase 4
• Study of the Usefulness of the Probiotic 'Lactobacillus Reuteri' in the Therapy of Quadruple Eradication of Helicobacter Pylori Infection in Usual Clinical Practice.Status unknownNCT03150394Phase 4
• 10 vs 14 Days Triple Therapy : H.Pylori Infection EradicationStatus unknownNCT03134378Phase 4
• Intraluminal Therapy for Helicobacter Pylori InfectionCompletedNCT03124420Phase 4
• Comparison Efficacy of 14-day Concomitant Therapy:Clarithromycin vs.Levofloxacin in Eradication of H.PyloriWithdrawnNCT03021590Phase 4
• Diagnosis Ability of Linked Color Imaging for Helicobacter Pylori Infection Compared With White Light ImagingStatus unknownNCT03011437
• Specimen Collection Study for H. Pylori TestingCompletedNCT02970110
• Doxycycline- and Furazolidone-containing Quadruple Regimen is Superior of Tailored TherapyStatus unknownNCT02894268Phase 4
• Comparison of Daily Single Dose Triple and Conventional Triple Therapies for Helicobacter Pylori InfectionCompletedNCT02711176Phase 4
• Potential Adverse Developmental and Nutritional Consequences of Helicobacter Pylori Infection in Israeli ChildrenStatus unknownNCT02654197
• The Effect of Probiotic Combination on Helicobacter Pylori Infection in ChildrenWithdrawnNCT02645201Not applicable
• Comparison of Dexlansoprazole-based Triple and Rabeprazole-based Triple Therapies for Helicobacter Pylori InfectionCompletedNCT02541786Phase 4
• Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for Rescue Treatment of Hp InfectionCompletedNCT02490839Phase 4
• Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for First-line Treatment of Hp InfectionCompletedNCT02483715Phase 4
• Helicobacter Pylori and Proton Pump InhibitorCompletedNCT02449941
• Dual Therapy With High Doses of Ilaprazole and Amoxicillin for Helicobacter Pylori InfectionCompletedNCT02401477Phase 4
• Efficacy on Helicobacter Pylori Eradication With Two Antibiotic RegimensCompletedNCT02395458Phase 4
• Randomized Study on Efficacy of Gemifloxacin-based Regimen for Helicobacter Pylori InfectionStatus unknownNCT02368470Phase 3
• The Diagnostic Validity of the Urea Breath TestCompletedNCT02359942Not applicable
• The Efficacy of the 7 Days Tailored Therapy as 2nd Rescue Therapy for Eradication of H. Pylori InfectionTerminatedNCT02359331Not applicable
• Efficacy and Safety of Basic Triple Therapy Including Ilaprazole on the First Line Eradication Treatment of H.PyloriCompletedNCT02352701
• Efficacy of Acetylcysteine-containing Triple Therapy in the First Line of Helicobacter Pylori InfectionStatus unknownNCT02249546Phase 4
• Endofaster Test for Helicobacter Pylori Detection in Patients on Proton Pump Inhibitor TherapyStatus unknownNCT02126722
• Gamma-Glutamyl Transpeptidase (GGT): A Potential Diagnostic Marker for Helicobacter Pylori InfectionsStatus unknownNCT02123771
• Comparison of the Eradications Rates of Sequential Therapy Versus Concomitant TherapyStatus unknownNCT02108184Phase 4
• Study of Pylopass Versus Placebo in Subjects Who Are Helicobacter Pylori Carriers and With Mild IndigestionCompletedNCT02051348Phase 2/3
• Eradication Rates of Helicobacter Pylori and Its Affecting FactorsCompletedNCT01922505
• Triple Therapy Versus Quadruple Therapies in the First Line Therapy of Helicobacter Pylori InfectionStatus unknownNCT01906879Phase 4
• 15-day Sequential Therapy for Helicobacter Pylori Infection in KoreaCompletedNCT01887249Phase 4
• Long-term Follow up Helicobacter Pylori Reinfection Rate After Second-Line Treatment: Bismuth-Containing Quadruple Therapy Versus Moxifloxacin-Based Triple TherapyCompletedNCT01792700Phase 4
• Levofloxacin and Bismuth-containing Therapy Versus Quadruple Therapy as Second-line Treatment of Resistant Helicobacter Pylori InfectionCompletedNCT01742429Phase 4
• Efficacy and Safety of InSan Bamboo Salt on Improvement of Helicobacter Pylori InfectionCompletedNCT01735136Not applicable
• Helicobacter Pylori Treatment in Immune Thrombocytopenic Purpura (ITP) PatientsCompletedNCT01730352Phase 2/3
• Standard Triple Therapy vs Sequential Therapy in Treatment of H Pylori InfectionStatus unknownNCT01723059Not applicable
• Additive Effect of Endonase on Eradication Rate of Second Line Therapy for HP InfectionTerminatedNCT01643785Not applicable
• 5 Day Concomitant Versus 10 Day Sequential Therapy for Eradication of H. Pylori InfectionCompletedNCT01544517Phase 3
• S1119 Peruvian H. Pylori Water Contamination StudyCompletedNCT01512875
• Immediate Detection of Helicobacter Infection With a New Electrochemical System.CompletedNCT01234389Not applicable
• A Trial of Standard vs Half Dose Rabeprazole, Clarithromycin, Metronidazole and Amoxicillin in the Treatment of Helicobacter Pylori InfectionCompletedNCT01219764Phase 4
• Efficacy of High Dose Dual Therapy, Sequential Therapy and Triple Therapy in H. Pylori EradicationCompletedNCT01163435Phase 4
• Helicobacter Pylori Eradication to Prevent Gastric CancerActive, not recruitingNCT01133951Not applicable
• Control of Helicobacter Pylori Infection by ProbioticsStatus unknownNCT01115296Not applicable
• The Efficacy of Susceptibility Test -Driven Sequential Therapy as the Third Line Therapy for Refractory Helicobacter Pylori InfectionCompletedNCT01032655Phase 4
• Control of Helicobacter Pylori Infection by Dietary Supplementation With Lactobacillus ReuteriStatus unknownNCT01028690Not applicable
• Efficacy of Acetilcysteine in 'Rescue' Therapy for Helicobacter Pylori Infection. Pilot StudyStatus unknownNCT00985608Phase 2
• Relation of Metabolic Rate of Omeprazole and Eradication of Helicobacter Pylori InfectionCompletedNCT00854451Phase 4
• Comparison of 7-day and 14-day Bismuth Based Quadruple Therapy for Secondary Helicobacter Pylori EradicationCompletedNCT00841854Phase 4
• Levofloxacin Versus Clarithromycin Triple Therapy in First-Line Treatment for Helicobacter Pylori EradicationCompletedNCT00816140Phase 4
• An Investigation of the Association Between Helicobacter Pylori Infection and Abdominal Pain in Cystic Fibrosis PatientsWithdrawnNCT00765401
• Efficacy and Safety Study of Finafloxacin Used in Helicobacter Pylori Infected PatientsCompletedNCT00723502Phase 2
• Clarithromycin, Amoxicillin, and Metronidazole Based Regimens to Treat Helicobacter Pylori Infections in ColombiaCompletedNCT00719420Phase 3
• Safety, Efficacy of Pylera BID Dosing in Eradication of H. PyloriWithdrawnNCT00712413Phase 3
• Helicobacter Pylori and Acute Alcohol Induced PancreatitisCompletedNCT00490386
• First Time in Man Study of Finafloxacin HydrochlorideCompletedNCT00483158Phase 1
• Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic PurpuraCompletedNCT00467571Phase 4
• Esomeprazole, Moxifloxacin and Amoxicilin for Rescue Therapy of Helicobacter Pylori InfectionStatus unknownNCT00455806Phase 3
• The Revolutions of Helicobacter Pylori Infection, Bacterial Density, and Histological Features After AntrectomyStatus unknownNCT00441831
• Sequential Therapy Versus Triple Therapy for Helicobacter Pylori Eradication: a Placebo-controlled TrialCompletedNCT00403364Phase 2/3
• Is Helicobacter Pylori Infection a Cause or Treatment Failure of Iron Deficiency Anemia in Children in Bangladesh?CompletedNCT00284700Not applicable
• Study of the Safety and Effectiveness of Rabeprazole in Treatment of Helicobacter Pylori Infection in Adults.CompletedNCT00216450Phase 4
• Risk Factors for Gastric Disease in Pediatric Helicobacter Pylori (H. Pylori)CompletedNCT00212225
• Second Line Therapy for the Cure of Helicobacter Pylori (H. Pylori) InfectionStatus unknownNCT00197418Phase 2/3
• Breath Ammonia Method for H. Pylori Detection: Phase IICompletedNCT00194688Phase 2
• The Role of CYP2C19 on the Eradication of H. Pylori Infection:Implication of PK/PD RelationshipsStatus unknownNCT00162877Not applicable
• Establish Epidemiologic Data of H. Pylori Infection in Children and Adolescents-Using C13-UBTCompletedNCT00155623
• Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. PyloriStatus unknownNCT00149084Phase 3
• Helicobacter Pylori and Dry EyeCompletedNCT00083291
• Infection and Cardiovascular DiseaseCompletedNCT00005547
• Inflammation, Infection, and Future Cardiovascular RiskCompletedNCT00005496

← Helicobacter Infections overview